Stratos Wealth Partners, Ltd. Glaukos Corp Transaction History

Stratos Wealth Partners, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$52.18 - $67.93 $7,827 - $10,189	-150 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$38.13 - $68.37 $5,719 - $10,255	150 New	150 $10,000
Q2 2018 Aug 13, 2018	SELL	$27.62 - $44.51 $4,143 - $6,676	-150 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$24.5 - $36.01 $3,675 - $5,401	150	150 $4,000

345

46.6M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.6B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.